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■ LETTER TO THE EDITOR ■
Ligneous inflammation is a rare systemic disorder which
can affect the conjunctiva, the female genital tract, the
upper and lower respiratory system, the gingiva, and
the ears [1–3]. The ocular mucosa is the most common
site involved. It can be diagnosed by the examination
of biopsy material histopathologically. In histopatho-
logic examination, chronic inflammatory changes, which
contain amorphous, eosinophilic, amyloid-like subepi-
thelial fibrin deposits, are encountered. Amorphous
deposits include fibrillar material consistent with fib-
rin [4]. These eosinophilic fibrin deposits are periodic
acid–Schiff (PAS)-positive material accompanied by
inflammatory cellular infiltration.
Ligneous inflammation is a recurrent, chronic inflam-
matory disorder for which curative treatment is not
available. Most gynecologists are unfamiliar with this
diagnosis, and lack of awareness of this unusual entity
can cause diagnostic difficulties [4].
Autosomal recessive inheritance is said to be respon-
sible for the disorder, and there are also familial cases
[5]. Recently, plasminogen deficiency has been found
to be responsible for ligneous changes because of an
inability to remove fibrin which is deposited in injured
mucosal tissue [6,7].
A 22-year-old married woman presented at our
gynecology clinic with dyspareunia and dysmenorrhea.
She had also been suffering from primary infertility for
two years. She complained about a white vaginal dis-
charge which included white plaques, and her symptoms
worsened prior to her menses.
On gynecologic examination, the cervix was found
to be deformed and there were hard white plaques,
which showed inflammatory reactions, at the vaginal
fornixes and around the cervix (Figures 1 and 2). In the
medical investigation of infertility, her basal hormones
(follicle-stimulating hormone, luteinizing hormone, es-
tradiol, thyroid-stimulating hormone, prolactin levels
on the third day of the menstrual cycle) were normal.
Her husband’s spermiogram was normal, and hystero-
salpingography revealed patent tubes and adequate uter-
ine cavity. Transvaginal ultrasonography was conducted,
and the uterus, ovaries and endometrium were found
to be normal. Because of her vaginal discharge, cervico-
vaginal culture, fresh examination and smear staining
were conducted. There was no evidence of Candida and
Trichomonas, and no clue cell was observed. The whiff
test and Chlamydia antigen test were negative, and
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Figure 1. Ligneous plaques (arrow) around the cervix.
Figure 2. Ligneous plaques (arrow) at the lateral fornix.
Gram-negative diplococci like Neisseria gonorrhoeae were
not observed. In the serologic tests, Chlamydia IgG and
IgM, herpes simplex virus 2 IgG and IgM were negative.
VDRL, rapid plasma reagin and Treponema pallidum hem-
agglutination tests were conducted for sexually transmit-
ted diseases like syphilis and were found to be negative.
The complete blood cell count, liver, kidney and thyroid
function tests, and blood glucose level were found to
have normal values. Additional tests were conducted,
including prothrombin time (12.3 seconds; reference,
11–15 seconds), fibrinogen (326 mg/dL; reference, 144–
430 mg/dL), D-dimer (0.38 mg/mL; reference, 0.00–
0.50 mg/mL), activated partial thromboplastin time
(32.5 seconds; reference, 25–40 seconds). In her lipid
profile screen, total cholesterol was 165 mg/dL (refer-
ence, < 200 mg/dL), HDL cholesterol was 42 mg/dL
(reference, 35–65 mg/dL), LDL cholesterol was 105 mg/
dL (reference, < 150 mg/dL) and lipoprotein(a) was
8 mg/dL (reference, 0–30 mg/dL). A hypercoagulability
screen was conducted; antithrombin III activity was
106% (reference, 80–120%), protein C activity was 109%
(reference, 70–130%), protein S activity was 130% (ref-
erence, 60–140%), activated protein C resistance was
183 seconds (reference, 120–300 seconds), factor XII
was 103% (reference, 60–140%). Plasminogen func-
tional activity was 50% of normal (reference, 55–145%),
tissue plasminogen activity (tPA) was 4 ng/mL (refer-
ence, 1–12 ng/mL), and plasminogen activator inhibitor
1 (PAI-1) was higher than normal at 4.2 U/mL (refer-
ence, 0.3–3.5 U/mL).
Histopathologically, samples of cervix and vagina
showed a fibrinous material surrounding the cervical
glands in the subepithelial area, disintegrated kera-
tinized cells, and infiltrations of lymphocytes and poly-
morphonuclear leucocytes. Acantholytic changes and
dyskeratotic cell groups were determined in the meta-
plastic squamous epithelium. There was subepithelial
deposition of a dense, amorphous, eosinophilic mate-
rial associated with intense inflammatory cell infiltra-
tion. The deposits showed positive staining for PAS and
phosphotungstic acid-hematoxylin (Figures 3 and 4).
Staining reactions showed that the amorphous material
contained fibrin.
The histopathology was consistent with ligneous
inflammation. Considering that the most frequent site
involved is the ocular mucosa, an ophthalmologic exam-
ination was held and no evidence of ligneous inflam-
mation was found. Autosomal recessive inheritance is
said to be responsible for the disorder, so chromosomal
analysis was made and a 46,XX karyotype was found.
From the patient’s medical history, her mother and
father were determined to be cousins. There was no
familial history of inflammatory eye disease and neither
of her sisters suffered from ligneous inflammation of
the female genital tract, eye or any other sites.
Ligneous inflammation is a rare systemic disorder
which can affect the conjunctiva, the female genital
tract, the upper and lower respiratory system, the gin-
giva, and the ears [1–3]. As the ocular mucosa is the
most common site of involvement, it has almost com-
pletely been in the province of ophthalmology. The num-
ber of cases which have ophthalmologic involvement is
much greater than those having female genital tract
involvement. Up to the present, 18 cases on ligneous
inflammation involving the female genital tract have
been published in English (Table). The cervix and vagina
appear to be the main genital sites of affliction. There
is no information or data on ligneous inflammation in
most gynecology textbooks. Ligneous inflammation may
cause infertility because of its effects on endometrial,
tubal, tubo-ovarian or even cervical function [3].
Ligneous inflammation was first mentioned in the lit-
erature as conjunctivitis in 1953 [16]. Bateman et al men-
tioned ligneous inflammation as an autosomal recessive
genetic disorder in 1986 [5]. In 1997, Mingers et al
reported homozygous type 1 plasminogen deficiency in
ligneous inflammation of the conjunctiva and extraoc-
ular pseudomembranous lesions [17]. In 1999, Schuster
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Figure 3. Positive staining for periodic acid–Schiff.
Figure 4. Amorphous, eosinophilic material in the subepi-
thelial area.
et al described compound heterozygous missense muta-
tions in the plasminogen gene in the development of
ligneous conjunctivitis [18]. In 2004, type 1 homozygous
plasminogen deficiency was reported in a patient who
had genital tract, middle ear and gingiva involvement
by Pantanowitz et al [7].
Ligneous changes are believed to appear owing 
to plasminogen deficiency which results in inability to
remove fibrin mostly in mucosal sites secondary to
previous injury or inflammation, resulting in increased
accumulation of fibrin deposits. In ligneous lesions, 
a preponderance of fibrin determines whether ligneous
lesions may arise because of defective fibrin degradation.
Ramsby et al [19] described impaired fibrin degradation
at both cellular and biochemical levels. Impaired fibrin
degradation can result from a variety of defects which
affect plasmin generation or activity, including deficiency
of plasminogen or t-PA, excess of PAI or plasmin acti-
vator inhibitor, or lipoprotein(a) or abnormalities in
matrix structure, function or interaction. Although our
patient’s tPA level was within normal limits, the PAI-1
level was higher and plasminogen was lower than normal.
Relative plasminogen deficiency which results in
hypofibrinolysis is known to arise following inhibition
of plasmin binding to fibrin and secondary to increased
plasminogen degradation. Binding of plasmin to fibrin
is inhibited by lipoprotein(a) [19]. Increased values of
lipoprotein(a) interfere with plasmin-mediated fibri-
nolysis [20]. Our patient had a normal lipoprotein(a)
level.
Heparin, steroids, hyaluronidase, cyclosporin and
α-chymotrypsin have been attempted in treatment, but
none of them have been consistently effective. Treatment
of ligneous conjunctivitis with topical plasmin was not
effective, while topical plasminogen had a good effect
[21]. In another study, two patients with ligneous con-
junctivitis and plasminogen deficiency were treated with
oral contraceptives, and an increment in plasminogen
was gained. Oral contraceptives inhibited the progres-
sion of ligneous changes in one of these patients and
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Table. Eighteen cases published in English on ligneous inflammation involving the female genital tract
Number of 
References patients Clinical characteristics Laboratory findings
reported
Lotan et al [8] 1 Extensive involvement of female Functional plasminogen activity 
genital tract, ear was 13% of normal
Karaer et al [9] 1 Involvement of female genital tract, Functional plasminogen activity 
oral mucosa, conjunctiva was 18% of normal
McCullough et al [10] 1 Involvement of female genital tract, Functional plasminogen activity 
conjunctiva, ear, gingiva was 12% of normal
Deen et al [11] 1 Involvement of female genital tract, Functional plasminogen activity 
no ocular or respiratory symptoms was 36% of normal
Tefs et al [12] 4 Report of 50 patients, four of whom NA
had female genital tract involvement
Kayikcioglu et al [2] 1 Involvement of female genital tract Functional plasminogen activity 
and conjunctiva was 16% of normal
Pantanowitz et al [7] 1 Involvement of female genital tract, Functional plasminogen activity 
middle ear, oral mucosa was 12% of normal
Chakravarti et al [13] 1 Involvement of female genital tract NA
and conjunctiva
Pantanowitz et al [4] 1 Involvement of female genital tract, NA
conjunctiva, ear, gingiva
Scurry et al [3] 2 Two women, both of them had genital NA
tract involvement and no ocular disease
Ridley and Morgan [14] 1 Involvement of female genital tract and NA
conjunctiva
Rubin et al [15] 1 Involvement of female genital tract, NA
conjunctiva, gingiva
Hidayat et al [1] 2 Report of 17 patients, two of whom had NA
female genital tract involvement
Total 18
NA = not available.
abolished the ligneous changes completely in the other
[22]. Oral contraceptive treatment is worth considering
in selected cases of plasminogen deficiency.
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